SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. – IOVA
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-58
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Xponential Fitness, Inc. – XPOF
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-99
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AlloVir, Inc. – ALVR
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Plug Power Inc. – PLUG
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Plug Power Inc. (“Plug Power” or the “Company”) (NASDAQ: PLUG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inspire Medical Systems, Inc. – INSP
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 6
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ON Semiconductor Corporation – ON
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ON Semiconductor Corporation (“onsemi” or the “Company”) (NASDAQ: ON). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-99
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Golden Heaven Group Holdings Ltd. – GDHG
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Golden Heaven Group Holdings Ltd. (“Golden Heaven” or the “Company”) (NASDAQ: GDHG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com o
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Mercury Systems, Inc. – MRCY
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Mercury Systems, Inc. (“Mercury” or the “Company”) (NASDAQ: MRCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ex
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. – EGRX
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-99
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of VNET Group, Inc. – VNET
NEW YORK, Jan. 14, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of VNET Group, Inc. (“VNET” or the “Company”) (NASDAQ: VNET). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 79